Balchem Q1 2026 Financial Performance and Strategic Insights
An overview of Balchem's financial results and strategic initiatives for Q1 2026, with insights into margin impacts and operational strategies.
Read postDetailed company information
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Jul 31, 2026
Earnings Transcript for 2026 - Q1Released: Apr 30, 2026
Earnings Transcript for 2025 - Q4Released: Feb 20, 2026
Earnings Transcript for 2025 - Q3Released: Oct 21, 2025
Earnings Transcript for 2025 - Q2Released: Aug 01, 2025
Earnings Transcript for 2025 - Q1Released: Apr 24, 2025
Earnings Transcript for 2024 - Q4Released: Feb 21, 2025
Earnings Transcript for 2024 - Q3Released: Oct 25, 2024
Earnings Transcript for 2024 - Q2Released: Jul 26, 2024
Earnings Transcript for 2024 - Q1Released: May 03, 2024
Earnings Transcript for 2023 - Q4Released: Feb 16, 2024
Earnings Transcript for 2023 - Q3Released: Oct 27, 2023
Earnings Transcript for 2023 - Q2Released: Jul 28, 2023
Earnings Transcript for 2023 - Q1Released: Apr 28, 2023
Earnings Transcript for 2022 - Q4Released: Feb 24, 2023
Earnings Transcript for 2022 - Q3Released: Nov 04, 2022
Earnings Transcript for 2022 - Q2Released: Jul 29, 2022
Earnings Transcript for 2022 - Q1Released: Apr 29, 2022
Earnings Transcript for 2021 - Q4Released: Feb 18, 2022
Earnings Transcript for 2021 - Q3Released: Oct 29, 2021
Earnings Transcript for 2021 - Q2Released: Aug 01, 2021
Earnings Transcript for 2021 - Q1Released: May 02, 2021
Earnings Transcript for 2020 - Q4Released: Feb 19, 2021
Earnings Transcript for 2020 - Q3Released: Oct 28, 2020
MTX Minerals Technologies Inc.
An overview of Balchem's financial results and strategic initiatives for Q1 2026, with insights into margin impacts and operational strategies.
Read postThis discussion analyzes Balchem's pricing strategies and margin impacts in Q1 2026, highlighting key drivers behind their financial performance.
Read postBalchem's Q1 2026 earnings reveal proactive pricing strategies to offset inflation, resulting in gross margin expansion despite inflationary headwinds, with cautious outlook on future margins due to timing lags.
Read postBalchem’s Q1 2026 earnings reveal a strategic focus on pricing to offset inflation, resulting in margin expansion driven by sales growth and operational efficiencies despite input cost pressures.
Read post